262A000039 - Acquisition of Blood Cardioplegia Sets for the Year 2026

This tender, identified as 262A000039, is for the acquisition of Blood Cardioplegia Sets for the year 2026. Blood cardioplegia is a critical component used during cardiac surgery to temporarily stop the heart's activity, allowing surgeons to operate safely on the heart muscle. These sets typically include specialized tubing, cannulas, and solutions designed for the delivery and management of cardioplegic solutions. The procurement is essential for healthcare facilities performing cardiac surgeries, ensuring they have a reliable supply of high-quality, sterile cardioplegia sets. The tender likely specifies the required technical specifications, quantities, and delivery schedules. The procuring entity seeks to ensure patient safety and surgical success by obtaining sets that meet stringent medical device standards. Potential suppliers are expected to be manufacturers or authorized distributors with the capability to provide these specialized medical supplies consistently and in compliance with all relevant healthcare regulations and quality certifications.

This is a supplies contract in the health and medical services and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 14,000.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.